157 related articles for article (PubMed ID: 12481432)
1. Efficacy of a glutathione S-transferase pi-activated prodrug in platinum-resistant ovarian cancer cells.
Townsend DM; Shen H; Staros AL; Gaté L; Tew KD
Mol Cancer Ther; 2002 Oct; 1(12):1089-95. PubMed ID: 12481432
[TBL] [Abstract][Full Text] [Related]
2. Cellular response to a glutathione S-transferase P1-1 activated prodrug.
Rosario LA; O'Brien ML; Henderson CJ; Wolf CR; Tew KD
Mol Pharmacol; 2000 Jul; 58(1):167-74. PubMed ID: 10860939
[TBL] [Abstract][Full Text] [Related]
3. Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): role of Ku autoantigen.
Frit P; Canitrot Y; Muller C; Foray N; Calsou P; Marangoni E; Bourhis J; Salles B
Mol Pharmacol; 1999 Jul; 56(1):141-6. PubMed ID: 10385694
[TBL] [Abstract][Full Text] [Related]
4. Protein phosphatases regulate DNA-dependent protein kinase activity.
Douglas P; Moorhead GB; Ye R; Lees-Miller SP
J Biol Chem; 2001 Jun; 276(22):18992-8. PubMed ID: 11376007
[TBL] [Abstract][Full Text] [Related]
5. Mapping of protein-protein interactions within the DNA-dependent protein kinase complex.
Gell D; Jackson SP
Nucleic Acids Res; 1999 Sep; 27(17):3494-502. PubMed ID: 10446239
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress induces nuclear loss of DNA repair proteins Ku70 and Ku80 and apoptosis in pancreatic acinar AR42J cells.
Song JY; Lim JW; Kim H; Morio T; Kim KH
J Biol Chem; 2003 Sep; 278(38):36676-87. PubMed ID: 12867423
[TBL] [Abstract][Full Text] [Related]
7. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining.
Douglas P; Gupta S; Morrice N; Meek K; Lees-Miller SP
DNA Repair (Amst); 2005 Aug; 4(9):1006-18. PubMed ID: 15941674
[TBL] [Abstract][Full Text] [Related]
8. Differential etoposide sensitivity of cells deficient in the Ku and DNA-PKcs components of the DNA-dependent protein kinase.
Jin S; Inoue S; Weaver DT
Carcinogenesis; 1998 Jun; 19(6):965-71. PubMed ID: 9667732
[TBL] [Abstract][Full Text] [Related]
9. DNA-dependent protein kinase (DNA-PK)-dependent cisplatin-induced loss of nucleolar facilitator of chromatin transcription (FACT) and regulation of cisplatin sensitivity by DNA-PK and FACT.
Dejmek J; Iglehart JD; Lazaro JB
Mol Cancer Res; 2009 Apr; 7(4):581-91. PubMed ID: 19372586
[TBL] [Abstract][Full Text] [Related]
10. Disruption of DNA-PK in Ku80 mutant xrs-6 and the implications in DNA double-strand break repair.
Chen F; Peterson SR; Story MD; Chen DJ
Mutat Res; 1996 Jan; 362(1):9-19. PubMed ID: 8538653
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
12. DNA-dependent protein kinase phosphorylation sites in Ku 70/80 heterodimer.
Chan DW; Ye R; Veillette CJ; Lees-Miller SP
Biochemistry; 1999 Feb; 38(6):1819-28. PubMed ID: 10026262
[TBL] [Abstract][Full Text] [Related]
13. The DNA-dependent protein kinase interacts with DNA to form a protein-DNA complex that is disrupted by phosphorylation.
Merkle D; Douglas P; Moorhead GB; Leonenko Z; Yu Y; Cramb D; Bazett-Jones DP; Lees-Miller SP
Biochemistry; 2002 Oct; 41(42):12706-14. PubMed ID: 12379113
[TBL] [Abstract][Full Text] [Related]
14. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis.
Kurimasa A; Ouyang H; Dong LJ; Wang S; Li X; Cordon-Cardo C; Chen DJ; Li GC
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1403-8. PubMed ID: 9990036
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of five cell models for chemoresistance studies of human ovarian carcinoma.
Li L; Luan Y; Wang G; Tang B; Li D; Zhang W; Li X; Zhao J; Ding H; Reed E; Li QQ
Int J Mol Med; 2004 Aug; 14(2):257-64. PubMed ID: 15254775
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of DNA-dependent protein kinase confers resistance to adriamycin.
Shen H; Schultz M; Kruh GD; Tew KD
Biochim Biophys Acta; 1998 Jul; 1381(2):131-8. PubMed ID: 9685611
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of chemosensitivity in multidrug-resistant human leukemia CEM cells by inhibition of DNA-dependent protein kinase using wortmannin.
Kim SH; Um JH; Dong-Won B; Kwon BH; Kim DW; Chung BS; Kang CD
Leuk Res; 2000 Nov; 24(11):917-25. PubMed ID: 11086175
[TBL] [Abstract][Full Text] [Related]
18. Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer.
Kavanagh JJ; Gershenson DM; Choi H; Lewis L; Patel K; Brown GL; Garcia A; Spriggs DR
Int J Gynecol Cancer; 2005; 15(4):593-600. PubMed ID: 16014111
[TBL] [Abstract][Full Text] [Related]
19. Binding of Ku and c-Abl at the kinase homology region of DNA-dependent protein kinase catalytic subunit.
Jin S; Kharbanda S; Mayer B; Kufe D; Weaver DT
J Biol Chem; 1997 Oct; 272(40):24763-6. PubMed ID: 9312071
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1997 Oct; 57(20):4488-92. PubMed ID: 9377558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
